• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COPD 患者在使用福莫特罗或福莫特罗和皮质类固醇治疗时的核 HSP90 和 HSP70。

Nuclear HSP90 and HSP70 in COPD patients treated with formoterol or formoterol and corticosteroids.

机构信息

Department of Clinical Pharmacology, Medical University of Bialystok, Poland.

出版信息

Eur J Med Res. 2009 Dec 7;14 Suppl 4(Suppl 4):104-7. doi: 10.1186/2047-783x-14-s4-104.

DOI:10.1186/2047-783x-14-s4-104
PMID:20156737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3521358/
Abstract

OBJECTIVE

Heat shock proteins assist cellular protein folding and are required for the normal activity of steroid receptors. In this study we assessed nuclear HSP90 and HSP70 proteins and mRNA levels in cells isolated from induced sputum of chronic obstructive pulmonary disease patients treated for 4 weeks with formoterol (F) or formoterol+budesonide (F/ICS).

METHODS

Nuclear heat shock protein levels were assessed by Western blot and specific mRNAs were quantified in cell lysates using qRT-PCR.

RESULTS

Both HSP90 and HSP70 protein levels were higher in the F/ICS-treated patients in comparison with the F-treated group (by 31%, P<0.05 and 28%, P<0.05, respectively), while specific mRNAs were lowered. HSP86/HSP89 and D6S182/HSP90-BETA were repressed by about 40% (P<0.05) while HSP70-1/HSP70-1A, HSP70-1B/HSP70-2, and HSP70-HSC54/HSC70 were repressed by 47% (P<0.01), 57% (P<0.01) and 65% (P<0.01), respectively.

CONCLUSIONS

It is possible that increased nuclear heat shock proteins may play a role in the attenuation of the response to glucocorticoids in COPD patients.

摘要

目的

热休克蛋白有助于细胞蛋白折叠,是甾体激素受体正常活动所必需的。本研究评估了慢性阻塞性肺疾病患者诱导痰中分离的细胞内核 HSP90 和 HSP70 蛋白及 mRNA 水平,这些患者接受福莫特罗(F)或福莫特罗+布地奈德(F/ICS)治疗 4 周。

方法

采用 Western blot 法评估核热休克蛋白水平,并使用 qRT-PCR 定量细胞裂解物中的特异性 mRNA。

结果

与 F 治疗组相比,F/ICS 治疗组患者的 HSP90 和 HSP70 蛋白水平均升高(分别升高 31%,P<0.05 和 28%,P<0.05),而特异性 mRNA 水平降低。HSP86/HSP89 和 D6S182/HSP90-BETA 分别下调约 40%(P<0.05),而 HSP70-1/HSP70-1A、HSP70-1B/HSP70-2 和 HSP70-HSC54/HSC70 分别下调 47%(P<0.01)、57%(P<0.01)和 65%(P<0.01)。

结论

核内热休克蛋白增加可能在 COPD 患者对糖皮质激素反应减弱中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7f/3521358/de49ed238e11/2047-783X-14-S4-104-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7f/3521358/de49ed238e11/2047-783X-14-S4-104-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7f/3521358/de49ed238e11/2047-783X-14-S4-104-1.jpg

相似文献

1
Nuclear HSP90 and HSP70 in COPD patients treated with formoterol or formoterol and corticosteroids.COPD 患者在使用福莫特罗或福莫特罗和皮质类固醇治疗时的核 HSP90 和 HSP70。
Eur J Med Res. 2009 Dec 7;14 Suppl 4(Suppl 4):104-7. doi: 10.1186/2047-783x-14-s4-104.
2
Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapy.慢性阻塞性肺疾病患者治疗后诱导痰细胞中 FKBP51 的增加。
Eur J Med Res. 2009 Dec 7;14 Suppl 4(Suppl 4):108-11. doi: 10.1186/2047-783x-14-s4-108.
3
Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial.布地奈德/福莫特罗单剂量氢氟烷烃压力定量吸入器治疗慢性阻塞性肺疾病的疗效和耐受性:一项为期1年的随机对照临床试验结果
Drugs. 2009;69(5):549-65. doi: 10.2165/00003495-200969050-00004.
4
Expression of CREB-binding protein and peroxisome proliferator-activated receptor gamma during formoterol or formoterol and corticosteroid therapy of chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者使用福莫特罗或福莫特罗与糖皮质激素联合治疗期间CREB结合蛋白和过氧化物酶体增殖物激活受体γ的表达
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:303-9.
5
The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.布地奈德/福莫特罗和沙美特罗/氟替卡松吸入治疗 COPD 患者和健康受试者后,其类固醇成分的生物利用度和气道清除率:一项随机对照试验。
Respir Res. 2009 Oct 31;10(1):104. doi: 10.1186/1465-9921-10-104.
6
Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.布地奈德/福莫特罗联合治疗在预防慢性阻塞性肺疾病急性加重方面优于氟替卡松/沙美特罗:PATHOS 研究。
J Intern Med. 2013 Jun;273(6):584-94. doi: 10.1111/joim.12067. Epub 2013 Apr 1.
7
Budesonide/formoterol: in chronic obstructive pulmonary disease.布地奈德/福莫特罗:用于慢性阻塞性肺疾病
Drugs. 2004;64(4):431-41; discussion 433-4. doi: 10.2165/00003495-200464040-00006.
8
Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD.布地奈德联合福莫特罗可改善 COPD 患者的运动耐量。
Respir Med. 2010 Oct;104(10):1450-9. doi: 10.1016/j.rmed.2010.07.006. Epub 2010 Aug 7.
9
Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease.多排螺旋 CT 评估布地奈德/福莫特罗在慢性阻塞性肺疾病患者中联合噻托溴铵的疗效。
Pulm Pharmacol Ther. 2013 Jun;26(3):336-41. doi: 10.1016/j.pupt.2013.01.005. Epub 2013 Jan 20.
10
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease.布地奈德/福莫特罗治疗慢性阻塞性肺疾病的疗效与安全性。
Eur Respir J. 2003 Jan;21(1):74-81. doi: 10.1183/09031936.03.00031402.

引用本文的文献

1
Systemic Markers of Lung Function and Forced Expiratory Volume in 1 Second Decline across Diverse Cohorts.不同队列中肺功能的系统标志物和 1 秒用力呼气量的下降。
Ann Am Thorac Soc. 2023 Aug;20(8):1124-1135. doi: 10.1513/AnnalsATS.202210-857OC.
2
Identification of a Thyroid Hormone Binding Site in Hsp90 with Implications for Its Interaction with Thyroid Hormone Receptor Beta.在热休克蛋白90中鉴定甲状腺激素结合位点及其与甲状腺激素受体β相互作用的意义
ACS Omega. 2022 Aug 9;7(33):28932-28945. doi: 10.1021/acsomega.2c02331. eCollection 2022 Aug 23.
3
Two-hybrid screening of FAM13A protein partners in lung epithelial cells.

本文引用的文献

1
Cyclophilin 40: an Hsp90-cochaperone associated with apo-steroid receptors.亲环蛋白40:一种与脱辅基类固醇受体相关的热休克蛋白90辅助伴侣蛋白。
Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1652-5. doi: 10.1016/j.biocel.2009.03.006. Epub 2009 Mar 24.
2
Elevated HSP27, HSP70 and HSP90 alpha in chronic obstructive pulmonary disease: markers for immune activation and tissue destruction.慢性阻塞性肺疾病中热休克蛋白27、热休克蛋白70和热休克蛋白90α升高:免疫激活和组织破坏的标志物
Clin Lab. 2009;55(1-2):31-40.
3
Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions.
肺上皮细胞中FAM13A蛋白伴侣的双杂交筛选
BMC Res Notes. 2020 Jan 3;12(1):804. doi: 10.1186/s13104-019-4840-9.
4
Chronic obstructive pulmonary disease and the hallmarks of aging.慢性阻塞性肺疾病与衰老的特征
Lung India. 2018 Jul-Aug;35(4):321-327. doi: 10.4103/lungindia.lungindia_266_17.
5
Steroid resistance in COPD is associated with impaired molecular chaperone Hsp90 expression by pro-inflammatory lymphocytes.慢性阻塞性肺疾病(COPD)中的类固醇抵抗与促炎淋巴细胞导致的分子伴侣热休克蛋白90(Hsp90)表达受损有关。
Respir Res. 2016 Oct 21;17(1):135. doi: 10.1186/s12931-016-0450-4.
小型综述:类固醇受体与分子伴侣的交叉:观察与问题
Mol Endocrinol. 2008 Oct;22(10):2229-40. doi: 10.1210/me.2008-0089. Epub 2008 May 1.
4
Cytoplasm-nuclear trafficking of CREB and CREB phosphorylation at Ser133 during therapy of chronic obstructive pulmonary disease.慢性阻塞性肺疾病治疗期间CREB的细胞质-细胞核转运及Ser133位点的CREB磷酸化
J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):437-44.
5
The glucocorticoid responses are shaped by molecular chaperones.糖皮质激素反应由分子伴侣塑造。
Mol Cell Endocrinol. 2007 Sep 15;275(1-2):2-12. doi: 10.1016/j.mce.2007.05.018. Epub 2007 Jun 2.
6
MAPK pathway mediates EGR-1-HSP70-dependent cigarette smoke-induced chemokine production.丝裂原活化蛋白激酶(MAPK)信号通路介导早期生长反应蛋白1(EGR-1)-热休克蛋白70(HSP70)依赖性香烟烟雾诱导的趋化因子生成。
Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1297-303. doi: 10.1152/ajplung.00194.2006.
7
Heat shock responses for understanding diseases of protein denaturation.用于理解蛋白质变性疾病的热休克反应。
Mol Cells. 2007 Apr 30;23(2):123-31.
8
Molecular chaperones: multiple functions, pathologies, and potential applications.分子伴侣:多种功能、病理学及潜在应用
Front Biosci. 2007 Jan 1;12:2588-600. doi: 10.2741/2257.
9
Chaperoning of glucocorticoid receptors.糖皮质激素受体的陪伴作用
Handb Exp Pharmacol. 2006(172):111-38. doi: 10.1007/3-540-29717-0_5.
10
Chaperones in preventing protein denaturation in living cells and protecting against cellular stress.伴侣蛋白在防止活细胞中的蛋白质变性以及抵御细胞应激方面的作用。
Handb Exp Pharmacol. 2006(172):1-42. doi: 10.1007/3-540-29717-0_1.